glp-1 vs contrave What Is Contrave? Exploring Its Role Compared to GLP‑1 Therapies Contrave vs. Wegovy—Which Is Better

Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and gradually titrated upward (5 mg, 7.5 mg, 10 mg, 12.5 mg, to a maximum of 15 mg) based on therapeutic response and tolerability

We safely navigate and medically manage the whole GLP-1 weight loss journey A medically managed approach to weight loss We have partnered with Eli Lily Pharmaceuticals who manufacture MOUNJARO to introduce a structured, medically managed weight loss service

Days 2-4: The Adjustment Phase What to expect: This is when most side effects appear

Shiiya, T

Structured fitness programs, evidence-based nutrition coaching, and whole-person wellness support create the conditions where every other intervention works better and lasts longer